19 results for author:"Navone N." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b. Karlou M., Lu J.F., Wu G., Maity S., Tzelepi V., Navone N.M., Hoang A., Logothetis C.J., Efstathiou E. Prostate 72:1638-1647(2012) · Mapped (2) |
| Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer. Sircar K., Huang H., Hu L., Liu Y., Dhillon J., Cogdell D., Aprikian A., Efstathiou E., Navone N., Troncoso P. et al. PLoS ONE 7:e31259-e31259(2012) · Mapped (8) |
| Activation of beta-catenin signaling in androgen receptor-negative prostate cancer cells. Wan X., Liu J., Lu J.F., Tzelepi V., Yang J., Starbuck M.W., Diao L., Wang J., Efstathiou E., Vazquez E.S. et al. Clin. Cancer Res. 18:726-736(2012) · Mapped (6) |
| Androgen regulation of 5alpha-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention. Li J., Ding Z., Wang Z., Lu J.F., Maity S.N., Navone N.M., Logothetis C.J., Mills G.B., Kim J. PLoS ONE 6:e28840-e28840(2011) · Mapped (3) |
| Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. Ferrando M., Gueron G., Elguero B., Giudice J., Salles A., Leskow F.C., Jares-Erijman E.A., Colombo L., Meiss R., Navone N. et al. Angiogenesis 14:467-479(2011) · Mapped (6) |
| Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Brenner J.C., Ateeq B., Li Y., Yocum A.K., Cao Q., Asangani I.A., Patel S., Wang X., Liang H., Yu J. et al. Cancer Cell 19:664-678(2011) · Mapped (8) |
| Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature. Mohamedali K.A., Li Z.G., Starbuck M.W., Wan X., Yang J., Kim S., Zhang W., Rosenblum M.G., Navone N.M. Clin. Cancer Res. 17:2328-2338(2011) · Mapped (12) |
| TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. Guo C.C., Dancer J.Y., Wang Y., Aparicio A., Navone N.M., Troncoso P., Czerniak B.A. Hum. Pathol. 42:11-17(2011) · Mapped (3) |
| Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Gueron G., De Siervi A., Ferrando M., Salierno M., De Luca P., Elguero B., Meiss R., Navone N., Vazquez E.S. Mol. Cancer Res. 7:1745-1755(2009) · Mapped (6) |
| Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. Li Z.G., Mathew P., Yang J., Starbuck M.W., Zurita A.J., Liu J., Sikes C., Multani A.S., Efstathiou E., Lopez A. et al. J. Clin. Invest. 118:2697-2710(2008) · Mapped (1) |
| Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Lin S.H., Lee Y.C., Choueiri M.B., Wen S., Mathew P., Ye X., Do K.A., Navone N.M., Kim J., Tu S.M. et al. Clin. Cancer Res. 14:3729-3736(2008) · Mapped (11) |
| Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Li Z.G., Yang J., Vazquez E.S., Rose D., Vakar-Lopez F., Mathew P., Lopez A., Logothetis C.J., Lin S.H., Navone N.M. Oncogene 27:596-603(2008) · Mapped (9) |
| A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Chen N., Ye X.C., Chu K., Navone N.M., Sage E.H., Yu-Lee L.Y., Logothetis C.J., Lin S.H. Cancer Res. 67:6544-6548(2007) · Mapped (17) |
| Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Cheng C.J., Ye X.C., Vakar-Lopez F., Kim J., Tu S.M., Chen D.T., Navone N.M., Yu-Lee L.Y., Lin S.H., Hu M.C. Mol. Cancer Res. 5:675-684(2007) · Mapped (11) |
| The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. Wang Z., Tseng C.-P., Pong R.-C., Chen H., McConnell J.D., Navone N., Hsieh J.-T. J. Biol. Chem. 277:12622-12631(2002) · UniProtKB (3) · Mapped (10) |
| Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Zhao X.Y., Malloy P.J., Krishnan A.V., Swami S., Navone N.M., Peehl D.M., Feldman D. Nat. Med. 6:703-706(2000) |
| Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. Zhao X.Y., Boyle B., Krishnan A.V., Navone N.M., Peehl D.M., Feldman D. J. Urol. 162:2192-2199(1999) · UniProtKB (1) |
| Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels. Navone N.M., Polo C.F., Frisardi A.L., Andrade N.E., Battle A.M. Int. J. Biochem. 22:1407-1411(1990) · Mapped (2) |
| A novel polymorphism near the mouse Int-2 locus. Navone N.M., Bianchi A.B., Angel J.M., Conti C.J. Mamm. Genome 3:296-297(1992) · Mapped (3) |